ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Soligenix Inc

Soligenix Inc (SNGX)

3.22
-0.10
( -3.01% )
Actualizado: 13:06:32

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
3.22
Postura de Compra
3.22
Postura de Venta
3.28
Volume Operado de la Acción
27,104
3.22 Rango del Día 3.31
1.8301 Rango de 52 semanas 19.20
Capitalización de Mercado [m]
Precio Anterior
3.32
Precio de Apertura
3.31
Última hora de negociación
13:06:32
Volumen financiero
US$ 88,031
Precio Promedio Ponderado
3.2479
Volumen promedio (3 m)
118,458
Acciones en circulación
2,509,499
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.33
Beneficio por acción (BPA)
-2.45
turnover
839k
Beneficio neto
-6.14M

Acerca de Soligenix Inc

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Heal... Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19). Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Soligenix Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNGX. The last closing price for Soligenix was US$3.32. Over the last year, Soligenix shares have traded in a share price range of US$ 1.8301 to US$ 19.20.

Soligenix currently has 2,509,499 shares in issue. The market capitalisation of Soligenix is US$8.33 million. Soligenix has a price to earnings ratio (PE ratio) of -1.33.

SNGX Últimas noticias

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment

HyBryte™ Clinical Results Demonstrate Continued Improvement Post-Treatment PR Newswire PRINCETON, N.J., Dec. 2, 2024 Significant Efficacy against Plaque Lesions Also Demonstrated with...

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell Lymphoma PR Newswire PRINCETON, N.J., Nov. 19, 2024 Phase 3 clinical study of HyBryte™ in CTCL initiating in...

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease

Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's Disease PR Newswire PRINCETON, N.J., Nov. 14, 2024 Study DUS-AUBD-01 opens patient...

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results

Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial Results PR Newswire PRINCETON, N.J., Nov. 8, 2024 PRINCETON, N.J., Nov. 8, 2024 /PRNewswire/ -- Soligenix, Inc...

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

PRINCETON, N.J., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing...

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin

Soligenix Receives Hong Kong Patent for Improved Production of Synthetic Hypericin PR Newswire PRINCETON, N.J., Oct. 22, 2024 Active Ingredient in HyBryte™ for the Treatment of Cutaneous T-Cell...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.13-3.880597014933.353.473.22833033.32144057CS
4-0.41-11.29476584023.633.873.21459933.45644129CS
12-0.45-12.26158038153.674.873.211184584.15552519CS
26-2.0696-39.12583182095.289614.82991.830113621677.1306507CS
52-7.18-69.038461538510.419.21.830116983338.49557924CS
156-183.692-98.2772641671186.912239.9761.830188213325.90537338CS
260-227.204-98.6025761205230.424883.21.83011073374214.85265156CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CTNTCheetah Net Supply Chain Service Inc
US$ 5.31
(183.96%)
109.29M
ZJKZJK Industrial Company Ltd
US$ 14.6773
(131.50%)
20.82M
GWAVGreenwave Technology Solutions Inc
US$ 0.6193
(69.67%)
408.19M
JYDJayud Global Logistics Ltd
US$ 1.089
(62.51%)
9.49M
JANXJanux Therapeutics Inc
US$ 61.96
(54.21%)
5.78M
REVBRevelation Biosciences Inc
US$ 0.5798
(-38.96%)
3.96M
STSSSharps Technology Inc
US$ 2.14
(-36.19%)
392.46k
OMEXOdyssey Marine Exploration Inc
US$ 0.48005
(-35.58%)
3.61M
GELSGelteq Ltd
US$ 2.635
(-31.03%)
238.77k
TTGTTech Target Inc
US$ 22.01
(-30.22%)
155.99k
GWAVGreenwave Technology Solutions Inc
US$ 0.6193
(69.67%)
408.19M
SMCISuper Micro Computer Inc
US$ 41.28
(-1.71%)
172.69M
CTNTCheetah Net Supply Chain Service Inc
US$ 5.31
(183.96%)
109.29M
CHRSCoherus BioSciences Inc
US$ 1.86
(35.77%)
105.59M
NVDANVIDIA Corporation
US$ 139.12
(0.35%)
104.19M

SNGX Discussion

Ver más
tw0122 tw0122 1 día hace
Phase 3 double success 
👍️0
Monroe1 Monroe1 4 semanas hace
Not many posts since then. "As for the industry’s initial reactions on the innovation front, the Pharmaceutical Research and Manufacturers of America (PhRMA) wants to “work with his administration to further strengthen our innovation ecosystem that enables the United States to lead the world in medicine development,” CEO Stephen Ubl said in a statement. “New medicines are transforming our ability to prevent, treat, and cure deadly disease, improving patient lives and helping to avoid the most expensive parts of our health care system.”

"“We are committed to working with the Trump administration and the new Congress to make our health care system work better for patients while preserving our unique ecosystem that enables greater innovation and lower costs for patients,” Ubl said.

Of course, a recent twist in Trump’s later campaign days was the introduction of Robert F. Kennedy Jr. as a prospect to head up healthcare. Kennedy, who scrapped his own campaign for the presidency in August, is widely known for his anti-vaccine rhetoric and conspiracies and was even temporarily banned from Instagram in 2021 for spreading misinformation about COVID-19 vaccines. At a rally in New York, Trump pledged to, if elected, allow Kennedy to “go wild on health” as well as “the medicines.”

Kennedy later delivered a grim message to the FDA on X, formerly Twitter, warning those who “work for the FDA and are part of this corrupt system” to “1. Preserve your records, and 2. Pack your bags.” Today, Fierce Biopharma
👍️0
gail gail 4 semanas hace
thx but that post was back in july.
👍️0
Monroe1 Monroe1 4 semanas hace
Now 1071 for your understanding the fundamentals. New FDA Commissioner soon to be will make some much needed changes and this company and others will be recognized positively and not as a threat to BP to be hamstrung as is presently the situation. Oversold so I will add to my little starter.
👍️0
Monksdream Monksdream 3 meses hace
SNGX under $4
👍️0
bikaver bikaver 5 meses hace
SNGX.....out today with a 2% loss
👍️0
Pedro2004 Pedro2004 5 meses hace
I agree. Thanks for the info.
👍️0
Invest-in-America Invest-in-America 5 meses hace
SNGX: It could very well hit that TODAY --- even after the Firm's pathetic dumping of more shares to Market yesterday, after the initial glorious run-up. (Wall Street makes Las Vegas, et al., look like 'child's-play'!!)
👍️0
boston127 boston127 5 meses hace
How is that $20 close working out?

Seems like you missed the mark. Wondering if it could hit $20 in 2 weeks.
👍️0
gail gail 5 meses hace
congrats, i got in too high today, holding.
👍️0
bikaver bikaver 5 meses hace
Grabbed some SNGX 7.15's in AH
👍️0
gail gail 5 meses hace
its an odd time to put….

..

out that type of news right as it was about to hit 15. i have seen these rebound well after such odd timing on that type of news.

lets see what happens.
👍️0
Pedro2004 Pedro2004 5 meses hace
Ouch. That one caught me.
👍️0
Pedro2004 Pedro2004 5 meses hace
Thank you. I was wondering what happened.
👍️0
TrendTrade2016 TrendTrade2016 5 meses hace
CHASERS FEELING SOME ANXIETY
👍️0
gail gail 5 meses hace
dang, they killed it. oh well, next.
👍️0
Awl416 Awl416 5 meses hace
On July 9, 2024, Soligenix, Inc. (the “Company”) entered into a warrant inducement agreement (the “Inducement Agreement”) with certain holders (the “Holders”) of the Company’s existing Warrant to Purchase Shares of Common Stock (“Existing Warrants”) to purchase shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company. Pursuant to the Inducement Agreement, the Holders agreed to exercise for cash their Existing Warrants to purchase up to 703,125 shares of Common Stock at an exercise price of $6.00 per share during the period from the date of the Inducement Agreement until 1:30 p.m., Eastern Time, on July 9, 2024. The aggregate gross proceeds to be received by the Company will depend on the number of Existing Warrants actually exercised by the Holders. If all of the Existing Warrants are exercised in connection with the Inducement Agreement, the Company would anticipate receiving aggregate gross proceeds of up to approximately $4,218,750 from the exercise of the Existing Warrants before deducting financial advisory fees and other expenses payable by us. There is, however, no guarantee that all of the Existing Warrants will be exercised by the Holder in accordance with the Inducement Agreement.
👍️0
TrendTrade2016 TrendTrade2016 5 meses hace
5.75 TO 12.00 WORKS...BE CAREFUL!!
👍️0
gail gail 5 meses hace
ugh.
👍️0
gail gail 5 meses hace
👍️ 1
TrendTrade2016 TrendTrade2016 5 meses hace
JUMPIN JESUS..THE POWER OF A TRIAL 3......LEFT SOME ON THIS TABLE!!!
👍️0
Invest-in-America Invest-in-America 5 meses hace
SNGX: Told ya not to worry --- $20 Close today, very likely.
👍️0
gail gail 5 meses hace
wow! just busted past 13, weeee!!!
👍️0
gail gail 5 meses hace
break 12 and its on!
👍️0
gail gail 5 meses hace
and here we goooo!
👍️0
gail gail 5 meses hace
it wants to break new highs, it appears.
👍️0
gail gail 5 meses hace
we gotta runner!!!!
👍️0
TrendTrade2016 TrendTrade2016 5 meses hace
double top at 12.00
👍️0
TrendTrade2016 TrendTrade2016 5 meses hace
here comes 12.00
👍️0
trader59 trader59 5 meses hace
Less than 1M shares in the O/S, volume already over 50 times that, and it's 10:15...
Robot wash trading, and when they turn those robots off, folks are going to be stuck with grossly overpriced stock.
🩳 1
Invest-in-America Invest-in-America 5 meses hace
SNGX: Hope it does better than that "dip" ya got yesterdary, Bro.
👍️0
TrendTrade2016 TrendTrade2016 5 meses hace
SNGX...BOUGHT THE DIP
👍️0
TIMGZ TIMGZ 5 meses hace
TOUCHING 900 EMA ON 5 SECONDS CHART SIGNALS EVENTUAL UPTREND, WE SHALL SEE. I AM STILL HOLDING MINE SINCE
OUR HONORABLE, IMPORTANT AND DIGNIFIED "INVEST-" ASSERTED TO THE MOON ON 1000% TARGET.
👍️0
Invest-in-America Invest-in-America 5 meses hace
SNGX: Who knew?????
👍️0
Invest-in-America Invest-in-America 5 meses hace
SNGX: Sarcasm, or compliment??? Or some linguistical item in between those two??? (HAH-HAH-HAH!!!)
👍️0
TIMGZ TIMGZ 5 meses hace
VERY BULLISH ON THIS
👍️0
bigfart bigfart 5 meses hace
It figures you would be here
👍️0
Invest-in-America Invest-in-America 5 meses hace
SNGX: I just rented an Elon Muskrat personal ROCKET, to see if I can CATCH the price here before it hits 1,000% in the Pre-M!!! (And of course, don't forget that Mr. MONK, "did it again"!!!)
👍️0
Awl416 Awl416 5 meses hace
Damn
👍️0
Monksdream Monksdream 5 meses hace
Whoops, I did it, again
👍️0
Awl416 Awl416 5 meses hace
Expanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma

Source: PR Newswire (US)
Study Supported by $2.6 Million FDA Orphan Products Development Grant
👍️0
Monksdream Monksdream 5 meses hace
SNGX new 52 week low
👍️0
StockItOut StockItOut 6 meses hace
Another @Zardiw early runner pick. I think he meant up.
👍️0
Monksdream Monksdream 6 meses hace
SNGX new 52 week low
👍️0
StockItOut StockItOut 6 meses hace
Well, just do a quick search if your memory is faulty, as you bring your memory into question.

Quick search and you find all of them. You seem to keep track.
👍️0
Zardiw Zardiw 6 meses hace
I don't recall any........

Z
👍️0
StockItOut StockItOut 6 meses hace
No kidding? How many DDAmanda subscribers do you have?
👍️0
StockItOut StockItOut 6 meses hace
There aren't or there really aren't? lol.
👍️0
Zardiw Zardiw 6 meses hace
Well, there really aren't any negative opinions on #DDAmanda, or I would have posted them...........There's a few guys that didn't make money, but that's their fault, not the software's.

Z
👍️0
StockItOut StockItOut 6 meses hace
Amazing the testimonials that sound like DDAmanda marketing.

What about the less favorable opinions of your DDAmanda members?

Your claimed testimonials don't change fact that you and #DDAmanda recommend really lame stocks as your picks.

You post after the break out, but claim your DDAmanda finds them before.

But you cannot show us 20 in a row DDAmanda posts of stocks a day or two prior to breakout.

Rather, you pick some, and some of these you then pump the crap out of.

Seems DDAmanda requires finding a stock to load up on and pump.


.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock